Table 1. Screening of CD8 T cell lines enriched in HCMV- or EBV-specific T cells for cross-reactivity to allogeneic MHC molecules.

Donor#	Molecular HLA class I typing						% of tetramer-positive T cells	Reactivity to allogeneic HLAa
	HLA-A*		HLA-B*		HLA-Cw*
pp65/A*0201-sorted T cell lines
D01	0201	0301	3501	4402	0401	0501	97	A*3101
D02	0201	33	08	14	07	08	98	none
D03	0201	0201	1302	5101	0202	0602	99	A*3201
D04	0201	ND	ND		ND		98	none
D05	0201	ND	ND		ND		99	none
D06	0201	ND	ND		ND		99	none
D07	0201	2301	2705	4402	0102	0509	98	none
D08	0201	2301	4101	4402	0501	1701	89	A*3001
D09	0201	30	08	44	04	07	98	none
D10	0201	0201	1501	4403	0304	0501	95	none
D11	0201	1101	0801	2705	01	07	97	none
BMLF1/A*0201-sorted T cell lines
D12	0201	3201	15	15	0303	04	93	none
D13	0201	0201	2705	4002	0102	1501	95	none
BZLF1/B*3501-sorted T cell lines
D14	0301	1101	0701	3501	04	07	92	none
D15	2402	3101	3501	4001	03	07	97	Cw*0602
D16	2402	3201	2705	3501	01	04	97	none

^aCD8 T cell lines were screened on COS-7 cells transfected with individual HLA-encoding cDNA and TNF-α production was measured after a 6h-coculture. All T cell lines were PBL-derived. ND : not determined.